11/19 – Eurocine Vaccines AB is moved to the Observation List
Following today’s press release from Spotlight, the company’s share will be moved to Spotlight’s Observation List. Information about the share: Shortname: EUCI ISIN-code: SE0001839069 Orderbook-ID:Read…
Eurocine Vaccines´ nasal influenza vaccine candidate Immunose™ FLU showed good safety in older adults
Eurocine Vaccines today announced good safety and tolerability in older adults, in the second clinical phase I/II study including their quadrivalent influenza vaccine candidate. Immunose™Read…
Eurocine Vaccines has completed dosing of its quadrivalent influenza vaccine candidate, Immunose™ FLU, in the second clinical study
– In the perspective of this year’s severe influenza outburst we are pleased to have chosen the broader quadrivalent, rather than trivalent, vaccine for ourRead…
Eurocine Vaccines takes advantage of yet another influenza season, launching its second clinical study on Immunose™ FLU
The purpose of the study is to evaluate safety, tolerability, as well as serological and mucosal immune responses against four influenza antigens in older adultsRead…
Eurocine Vaccines obtains authorization to conduct the next study with Immunose™ FLU
Eurocine Vaccines submitted applications to the Swedish Medical Products Agency, MPA, and to the Ethics Committee in early November. The Company announced today that authorizationsRead…
Eurocine Vaccines Challenges the Flu
“The issued patent in the US earlier this year proves the success of our patent strategy. We now hold at least one granted patent fromRead…
Pulsen på mukosalt
Nyligen hemkommen från årets Influenza Vaccines for the World 2017 * summerar Dr. Anna-Karin Maltais, Forsknings- och utvecklingschef på Eurocine Vaccines, här de viktigaste insikternaRead…
Pulsen på mukosalt
Nyligen hemkommen från årets Influenza Vaccines for the World 2017 * summerar Dr. Anna-Karin Maltais, Forsknings- och utvecklingschef på Eurocine Vaccines, här de viktigaste insikternaRead…
Eurocine Vaccines has received notice of allowance for a US patent application
Eurocine Vaccines has received notice of allowance in the US for one of its patent applications. The patent application, involving the company´s nasal influenza vaccineRead…
Eurocine Vaccines has received notice of allowance for a US patent application
Eurocine Vaccines has received notice of allowance in the US for one of its patent applications. The patent application, involving the company´s nasal influenza vaccineRead…